MYOD1 (L122R) mutations are associated with spindle cell and sclerosing rhabdomyosarcomas with aggressive clinical outcomes
Open Access
- 1 December 2016
- journal article
- Published by Elsevier BV in Laboratory Investigation
- Vol. 29 (12), 1532-1540
- https://doi.org/10.1038/modpathol.2016.144
Abstract
No abstract availableKeywords
This publication has 27 references indexed in Scilit:
- Frequency of EGFR Mutations in 907 Lung Adenocarcioma Patients of Indian EthnicityPLOS ONE, 2013
- Oncogene Mutation Profiling of Pediatric Solid Tumors Reveals Significant Subsets of Embryonal Rhabdomyosarcoma and Neuroblastoma with Mutated Genes in Growth Signaling PathwaysClinical Cancer Research, 2012
- Smoking, Gender, and Ethnicity Predict Somatic BRAF Mutations in Colorectal CancerCancer Epidemiology, Biomarkers & Prevention, 2010
- Somatic mutations are present in all members of the AKT family in endometrial carcinomaBritish Journal of Cancer, 2009
- PI3K pathway alterations in cancer: variations on a themeOncogene, 2008
- Sclerosing RhabdomyosarcomaAmerican Journal of Clinical Pathology, 2008
- Sclerosing Rhabdomyosarcomas in Children and Adolescents: A Clinicopathologic Review of 13 Cases from the Intergroup Rhabdomyosarcoma Study Group and Children's Oncology GroupPediatric and Developmental Pathology, 2004
- Spindle Cell Rhabdomyosarcoma (So-Called) in AdultsThe American Journal of Surgical Pathology, 1998
- Rhabdomyosarcomas do not contain mutations in the DNA binding domains of myogenic transcription factors.JCI Insight, 1994
- Spindle Cell RhabdomyosarcomaThe American Journal of Surgical Pathology, 1992